DOI QR코드

DOI QR Code

Distinctive clinical features of HPeV-3 infection in 2 neonates with a sepsis-like illness

  • Yeom, Jung Sook (Department of Pediatrics, Gyeongsang National University School of Medicine) ;
  • Park, Ji Sook (Department of Pediatrics, Gyeongsang National University School of Medicine) ;
  • Seo, Ji-Hyun (Department of Pediatrics, Gyeongsang National University School of Medicine) ;
  • Park, Eun Sil (Department of Pediatrics, Gyeongsang National University School of Medicine) ;
  • Lim, Jae-Young (Department of Pediatrics, Gyeongsang National University School of Medicine) ;
  • Park, Chan-Hoo (Department of Pediatrics, Gyeongsang National University School of Medicine) ;
  • Woo, Hyang-Ok (Department of Pediatrics, Gyeongsang National University School of Medicine) ;
  • Youn, Hee-Shang (Department of Pediatrics, Gyeongsang National University School of Medicine) ;
  • Lee, Ok Jeong (Department of Pediatrics, Sejong General Hospital) ;
  • Han, Tae-Hee (Department of Laboratory Medicine, Inje University Sanggyepaik Hospital, Inje University College of Medicine) ;
  • Chung, Ju-Young (Department of Pediatrics, Inje University Sanggyepaik Hospital, Inje University College of Medicine)
  • 투고 : 2016.02.03
  • 심사 : 2016.05.16
  • 발행 : 2016.07.15

초록

We report a human parechovirus-3 (HPeV-3) infection in 2 neonates who had prolonged fever (>5 days) with palmar-plantar erythema. This distinctive rash was observed 4-5 days after fever onset, just before defervescence. Elevated aspartate aminotransferase, lactate dehydrogenase, and ferritin levels were characteristic laboratory findings in the 2 cases, suggesting tissue damage caused by hypercytokinemia. Case 1 was treated with intravenous immunoglobulin, considering the possibility of severe systemic inflammatory responses. The initial ferritin level was 385 ng/mL (range, 0-400 ng/mL); however, the level increased to 2,581 ng/dL on day 5 after fever onset. Case 2 presented with milder clinical symptoms, and the patient recovered spontaneously. HPeV-3 was detected in cerebrospinal fluid and/or blood samples, but no other causative agents were detected. The findings from our cases, in accordance with recent studies, suggest that clinical features such as palmar-plantar erythema and/or hyperferritinemia might be indicators of HPeV-3 infection in neonates with sepsis-like illness. In clinical practice, where virology testing is not easily accessible, clinical features such as palmar-plantar erythema and/or hyperferritinemia might be helpful to diagnose HPeV-3 infection.

키워드

참고문헌

  1. Ito M, Yamashita T, Tsuzuki H, Takeda N, Sakae K. Isolation and identification of a novel human parechovirus. J Gen Virol 2004;85(Pt 2):391-8. https://doi.org/10.1099/vir.0.19456-0
  2. Harvala H, Simmonds P. Human parechoviruses: biology, epidemiology and clinical significance. J Clin Virol 2009;45:1-9. https://doi.org/10.1016/j.jcv.2009.03.009
  3. Selvarangan R, Nzabi M, Selvaraju SB, Ketter P, Carpenter C, Harrison CJ. Human parechovirus 3 causing sepsis-like illness in children from midwestern United States. Pediatr Infect Dis J 2011;30:238-42. https://doi.org/10.1097/INF.0b013e3181fbefc8
  4. Yuzurihara SS, Ao K, Hara T, Tanaka F, Mori M, Kikuchi N, et al. Human parechovirus-3 infection in nine neonates and infants presenting symptoms of hemophagocytic lymphohistiocytosis. J Infect Chemother 2013;19:144-8. https://doi.org/10.1007/s10156-012-0420-9
  5. Verboon-Maciolek MA, Krediet TG, Gerards LJ, de Vries LS, Groenendaal F, van Loon AM. Severe neonatal parechovirus infection and similarity with enterovirus infection. Pediatr Infect Dis J 2008;27:241-5. https://doi.org/10.1097/INF.0b013e31815c1b07
  6. Hara S, Kawada J, Kawano Y, Yamashita T, Minagawa H, Okumura N, et al. Hyperferritinemia in neonatal and infantile human parechovirus-3 infection in comparison with other infectious diseases. J Infect Chemother 2014;20:15-9. https://doi.org/10.1016/j.jiac.2013.11.002
  7. Shoji K, Komuro H, Miyata I, Miyairi I, Saitoh A. Dermatologic manifestations of human parechovirus type 3 infection in neonates and infants. Pediatr Infect Dis J 2013;32:233-6.
  8. Shoji K, Komuro H, Kobayashi Y, Shike T, Funaki T, Katsuta T, et al. An infant with human parechovirus type 3 infection with a distinctive rash on the extremities. Pediatr Dermatol 2014;31:258-9. https://doi.org/10.1111/j.1525-1470.2012.01819.x
  9. Seo JH, Yeom JS, Youn HS, Han TH, Chung JY. Prevalence of human parechovirus and enterovirus in cerebrospinal fluid samples in children in Jinju, Korea. Korean J Pediatr 2015;58:102-7. https://doi.org/10.3345/kjp.2015.58.3.102
  10. Verboon-Maciolek MA, Groenendaal F, Hahn CD, Hellmann J, van Loon AM, Boivin G, et al. Human parechovirus causes encephalitis with white matter injury in neonates. Ann Neurol 2008;64:266-73. https://doi.org/10.1002/ana.21445
  11. Verboon-Maciolek MA, Utrecht FG, Cowan F, Govaert P, van Loon AM, de Vries LS. White matter damage in neonatal enterovirus meningoencephalitis. Neurology 2008;71:536.
  12. Asano Y, Yoshikawa T, Suga S, Yazaki T, Hata T, Nagai T, et al. Viremia and neutralizing antibody response in infants with exanthem subitum. J Pediatr 1989;114(4 Pt 1):535-9. https://doi.org/10.1016/S0022-3476(89)80689-4
  13. Wildenbeest JG, Wolthers KC, Straver B, Pajkrt D. Successful IVIG treatment of human parechovirus-associated dilated cardiomyopathy in an infant. Pediatrics 2013;132:e243-7. https://doi.org/10.1542/peds.2012-1136
  14. Aizawa Y, Watanabe K, Oishi T, Hirano H, Hasegawa I, Saitoh A. Role of maternal antibodies in infants with severe diseases related to human parechovirus type 3. Emerg Infect Dis 2015;21:1966-72. https://doi.org/10.3201/eid2111.150267
  15. Westerhuis BM, Koen G, Wildenbeest JG, Pajkrt D, de Jong MD, Benschop KS, et al. Specific cell tropism and neutralization of human parechovirus types 1 and 3: implications for pathogenesis and therapy development. J Gen Virol 2012;93(Pt 11):2363-70. https://doi.org/10.1099/vir.0.043323-0

피인용 문헌

  1. Clinical Differences between Enterovirus and Human Parechovirus in Children and Infants vol.28, pp.1, 2016, https://doi.org/10.26815/acn.2019.00227
  2. Acral manifestations associated with infection vol.38, pp.6, 2016, https://doi.org/10.1111/pde.14831